Skip to main content

Table 3 The characteristics and results of the interventions used in each study

From: Comparison of outcomes between surgery and non-surgery after conversion therapy for advanced gastric cancer with unresectable factors: a systematic review and meta-analysis

Author + year

MF-U(month)

OS-1

OS-3

OS-5

PFS-1

PFS-3

PFS-5

CR

PR

Group

 

S

NS

S

NS

S

NS

S

NS

S

NS

S

NS

S

NS

S

NS

Wang 2014 [25]

12.4

8

28

12

20

19

28

15

20

N/A

N/A

N/A

N/A

13

28

15

20

15

28

20

20

N/A

N/A

N/A

N/A

0

28

2

20

20

28

1

20

Fukuchi 2015 [24]

15

6

40

55

111

20

40

100

111

23

40

110

111

26

40

111

111

26

40

111

111

25

40

111

111

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Ito 2015 [23]

24.8

0

14

31

56

9

14

51

56

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Kinoshita 2015 [22]

60

4

34

15

23

17

34

23

23

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Li 2015 [21]

N/A

7

25

14

24

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

17

25

24

24

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

14

25

7

24

Sato 2017 [8] 

20.5

1

33

23

67

12

33

54

67

24

33

67

67

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Yamada 2016 [20]

12

17

44

19

28

34

44

25

28

40

44

28

28

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Fukuchi 2018 [19]

11

4

31

49

63

15

31

63

63

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

2

31

0

63

22

31

6

63

Ohnuma 2021 [7]

39.3

9

44

14

44

26

44

39

44

36

44

44

44

16

44

32

44

31

44

42

44

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Li 2021 [18]

14.1

16

40

24

40

40

40

40

40

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

7

40

3

40

14

40

11

40

Shinkai 2022 [16]

31.8

7

33

9

19

21

33

18

19

25

33

19

19

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

1

33

0

19

7

33

4

19

Liang 2023 [15]

16.7

13

42

61

94

39

42

94

94

N/A

N/A

N/A

N/A

15

42

76

94

39

42

94

94

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

  1. N/A not available, S surgery, NS non- surgery, CR complete response, PR partial responses